Where does Austen Bioinnovation Institute IN Akron rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Austen Bioinnovation Institute IN Akron ranks #44,952 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Austen Bioinnovation Institute IN Akron hold?

Austen Bioinnovation Institute IN Akron holds 5 US utility patents granted between 2016 and 2020, spanning 5 technology areas.

What is Austen Bioinnovation Institute IN Akron's Innovation Score?

Austen Bioinnovation Institute IN Akron has an Innovation Score of 25.4 out of 100 (17th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Austen Bioinnovation Institute IN Akron focus on?

Austen Bioinnovation Institute IN Akron's top technology area is A61B (DIAGNOSIS; SURGERY; Identification) with 3 patents, ranking #4,165 of 7,127 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

Is Austen Bioinnovation Institute IN Akron's patent grant rate increasing or decreasing?

Austen Bioinnovation Institute IN Akron's recent grant velocity is -75% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Austen Bioinnovation Institute IN Akron's patents?

Austen Bioinnovation Institute IN Akron's patents average 18.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Austen Bioinnovation Institute IN Akron patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Austen Bioinnovation Institute IN Akron

USPTO PatentsView assignee record - 5 granted patents across 5 technology areas, recorded in grant years 2016–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Austen ranks #44,952 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 5 technology areas.

#44,952
of 49,997 US assignees by volume: 17th percentile
by Innovation Score (25.4/100): 18.8
avg claims per patent: -75%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R44952 · US Corporation #44,952 · 5 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 5 grants
LOWER-Q #44,952/49,997
PHOTO-FINISH Auson Pharmaceuticals
CPC-NARROW A61B · 5 areas
INNOV-THIN 25.4/100
CLAIMS-RICH 18.8 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -75% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Auson Pharmaceuticals Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Austen’s 25.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.2 pts (24%) Velocity 0.0 pts (0%) Breadth 7.9 pts (31%) Claim depth 11.3 pts (44%)

Qualcomm Incorporated · highest

85
Austen Bioinnovation… · this assignee

25
3D Lighting… · lowest

7

What this shows Austen's Innovation Score is 25.4/100 (17th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Austen?

Each dot is one of Austen’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Austen’s own 18.8 claims/patent is ABOVE the 13.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Austen vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Austen's grants concentrate

Austen Bioinnovation Institute IN Akron is a focused PatentsView assignee: 5 CPC subclasses with 60% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2018 (3 grants) versus a trough of 1 in 2016. By volume, Austen sits between Auson Pharmaceuticals Inc. and Autel Robotics USA LLC.

Auson Pharmaceuti…

5
Aussie Wine Group…

5
Aust Development

5
Austem

5
Australian MUD PTY

5
Australis Aquacul…

5
Autel NEW Energy

5
Autel Robotics USA

5
Austen Bioinnovat… ◀

5

What this shows Austen holds 5 patents at rank #44,682, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Austen

By rank, the assignees closest to #44,682 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Austen's primary technology class.

Austen's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

25 17th percentile higher than 17% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2020

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Austen Bioinnovation Institute IN Akron patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	1	20.0%
2018	3	60.0%
2020	1	20.0%

Which technologies does Austen Bioinnovation Institute IN Akron patent most?

A61B - DIAGNOSIS; SURGERY; Identification 3

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 2

Y10T - Technical Subjects Covered BY Former US Classification 1

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

G01F - Measuring Volume, Volume Flow, Mass Flow OR Liquid LEVEL; Metering BY Volume 1

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Austen Bioinnovation Institute IN Akron's patent record in context - here's where to go next.

Austen Bioinnovation Institute IN Akron's lead technology class is A61B (DIAGNOSIS; SURGERY; Identification), 60% of its portfolio - see every assignee active in that class. Explore A61B
Ranked #44,952 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Austen Bioinnovation Institute IN Akron against Auson Pharmaceuticals Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 25.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.